Please login to the form below

Not currently logged in
Email:
Password:

Vivid

This page shows the latest Vivid news and features for those working in and with pharma, biotech and healthcare.

Lucid launches rare and specialist disease agency

Lucid launches rare and specialist disease agency

Lucid launches rare and specialist disease agency. Vivid MedComms will be headed by Alison Cantle. ... UK-based Lucid Group, has opened Vivid Medcomms, a new agency that will focus on rare diseases and be based in Buckinghamshire, UK.

Latest news

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • The rising prevalence of diabetes in Europe The rising prevalence of diabetes in Europe

    Hyperbole is common when discussing diabetes but vivid imagery that paints the condition as a ticking time bomb or epidemic is a necessary part of understanding the scale of the problem.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics